Category Archives: News

HIMSS AsiaPac 18 – Leadership voices: healthcare anytime, anywhere

The HIMSS AsiaPac 18 Conference in Brisbane officially started today with an opening plenary, Leadership Voices: Healthcare Anytime, Anywhere featuring five healthcare leaders and experts with experience from different parts of the globe. Dr Charles Alessi, Chief Clinical Officer, HIMSS, the moderator of the panel started with an opening question to the panelists – what are… Read More: HIMSS AsiaPac 18 – Leadership voices: healthcare anytime, anywhere »

Can this Amazonian diet offer a solution to heart disease?

In the United States, hundreds of thousands of people die every year from causes related to heart disease. Cardiovascular health is a fragile asset, but one population from the Bolivian Amazon seems to possess the secret to a life free of heart disease. What is it? Researchers map out the diet that may have rendered… Read More: Can this Amazonian diet offer a solution to heart disease? »

Can AI Address Health Care's Red-Tape Problem?

Executive Summary Productivity in the United States’ health care industry is declining – and has been ever since World War II. As the cost of treating patients continues to rise, life expectancies in America are beginning to fall. But there is mounting evidence that artificial intelligence (AI) can begin to reverse the downward spiral in… Read More: Can AI Address Health Care's Red-Tape Problem? »

FDA Approves Udenyca (pegfilgrastim-cbqv), a Biosimilar to Neulasta

FDA Approves Udenyca (pegfilgrastim-cbqv), a Biosimilar to Neulasta Print this page REDWOOD CITY, Calif., Nov. 02, 2018 (GLOBE NEWSWIRE) — Coherus BioSciences, Inc. (NASDAQ: CHRS), today announced that the U.S. Food and Drug Administration (FDA) has approved Udenyca (pegfilgrastim-cbqv), the first pegfilgrastim biosimilar approved by both the FDA and the European Commission (EC) for patients… Read More: FDA Approves Udenyca (pegfilgrastim-cbqv), a Biosimilar to Neulasta »